TetraLogic Pharmaceuticals Mutual Funds

Health Care & Life Sciences » Biotechnology | TetraLogic Pharmaceuticals Corp.

TetraLogic Pharmaceuticals Corp. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Herculis Partners Aries Fund

90,000

0.37%

0.04%

07/31/2018

4,169

0.02%

09/05/2018

BlackRock (Japan) US Small Cap Growth Equity Open Mother Fund

-5,767

09/20/2016

View Profile

Address	343 Phoenixville Pike Malvern Pennsylvania 19355 United States
Employees	-
Website	http://www.tetralogicpharma.com
Updated	07/08/2019
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. It products include Birinapant, and SHAPE. The company was founded by John M.